Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT00494117
Registration number
NCT00494117
Ethics application status
Date submitted
28/06/2007
Date registered
29/06/2007
Date last updated
27/07/2010
Titles & IDs
Public title
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
Query!
Scientific title
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
Query!
Secondary ID [1]
0
0
X07- 0052
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Heart Failure, Congestive
0
0
Query!
Sleep Apnea Syndromes
0
0
Query!
Condition category
Condition code
Respiratory
0
0
0
0
Query!
Sleep apnoea
Query!
Cardiovascular
0
0
0
0
Query!
Coronary heart disease
Query!
Cardiovascular
0
0
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Treatment: Devices - ApneaLink
Treatment: Devices: ApneaLink
A two channel sleep screening device for the assessment of Sleep Disordered Breathing.
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Eligibility
Key inclusion criteria
* Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Malignant disease affecting gas exchange or respiratory parameters
* Medications compromising breathing with no adverse affects on heart failure
* Clinically significant (moderate to severe) asthma requiring therapy
* Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)
* Severe pulmonary hypertension
* Heart failure due to alcohol abuse or chemotherapy
* Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)
* Alcohol consumption > 80g/day
* Patients receiving home Oxygen
* Methicillin- resistant Staphylococcus aureus infection
* Narcolepsy
* Cataplexy
* Enrolled in any concurrent study, that may confound the results of this study.
* Inability or refusal to sign the Patient Consent Form
* Inability or refusal to adhere to protocol requirements
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/06/2007
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/03/2010
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
50
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
Royal Prince Alfred Hospital - Camperdown
Query!
Recruitment postcode(s) [1]
0
0
2050 - Camperdown
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
ResMed
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.
Query!
Trial website
https://clinicaltrials.gov/study/NCT00494117
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Rachel A Coxon, BE/MBiomedE
Query!
Address
0
0
ResMed/The University of New South Wales
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT00494117
Download to PDF